Cooley partner tapped to co-lead DLA Piper capital markets practice [Reuters]
IN8bio, Inc. (INAB)
Company Research
Source: Reuters
a partner from Cooley who has handled initial public offerings for companies in the technology, life sciences and other industries. Joshua Kaufman has joined DLA Piper's New York and Miami offices as a partner, the international firm said. He represented biopharmaceutical company IN8bio and software startup Sprinklr in their initial public offerings in recent years. His clients have also included Shake Shack and Gamida Cell, an Israeli biopharmaceutical company, according to his former profile on Cooley's website. DLA Piper is actively expanding its dealmaking capabilities in life sciences and technology "and we are confident that Josh will provide a significant addition to our strong capital markets team in these key sectors," Andrew Gilbert, who chairs DLA Piper's U.S. corporate practice, said in a statement. A Cooley spokesperson said the firm wished Kaufman well. Kaufman's hire comes one week after DLA Piper added two other partners to its ranks, including former Merck e
Show less
Read more
Impact Snapshot
Event Time:
INAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INAB alerts
High impacting IN8bio, Inc. news events
Weekly update
A roundup of the hottest topics
INAB
News
- IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingGlobeNewswire
- IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]Yahoo! Finance
- IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceGlobeNewswire
- Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio's Preclinical Candidate Shows Potential [Yahoo! Finance]Yahoo! Finance
INAB
Earnings
- 11/9/23 - Beat
INAB
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- INAB's page on the SEC website